Evang. Kliniken Essen-Mitte
Essen, North Rhine-Westphalia, 45276, Germany
NCT Number: NCT04867967
Primary study objectives
1. evaluate the short-term effect of yoga intervention in addition to routine care on headache frequency in patients with frequent or chronic tension-type headache compared to routine care alone (waiting group). 2. to evaluate the short-term effect of yoga intervention in addition to routine care on headache frequency in patients with frequent episodic or chronic tension-type headache compared with stress management through mindfulness-based stress reduction (MBSR) in addition to routine care.
Secondary study objectives
Evaluation of the medium-term effect of the intervention on headache frequency as well as the short- and medium-term effect on the secondary target parameters in comparison to the waiting group and MBSR. Further evaluation of the safety and acceptability of the intervention.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Essen, North Rhine-Westphalia, 45276, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Classical Iyengar Yoga intervention, especially designed for headache patients. Note: First administered face-to-face, due to Covid-restrictions changed to online classes
Standardazied Mindfulness-based stress reduction intervention Note: First administered face-to-face, due to Covid-restrictions changed to online classes
Time frame: post-intervention (8 weeks)
Headache Frequency self-reported by a headache diary
Time frame: follow-up (20 weeks)
Headache Frequency self-reported by a headache diary
Time frame: post-intervention (8 weeks)
Duration of headache episodes self-reported by a headache diary
Time frame: follow-up (20 weeks)
Duration of headache episodes self-reported by a headache diary
Time frame: post-intervention (8 weeks)
Numeric rating scale
Time frame: follow-up (20 weeks)
Numeric rating scale (NRS)
Time frame: post-intervention (8 weeks)
Pain medication use self-reported by a headache diary
Time frame: follow-up (20 weeks)
Pain medication use self-reported by a headache diary
Time frame: post-intervention (8 weeks)
Headche Impact Test 6 (HIT-6)
Time frame: follow-up (20 weeks)
Headche Impact Test 6 (HIT-6)
Time frame: post-intervention (8 weeks)
SF-36 questionaire
Time frame: follow-up (20 weeks)
SF-36 questionaire
Time frame: post-intervention (8 weeks)
Depression and Anxiety scale (DAAS)
Time frame: follow-up (20 weeks)
Depression and Anxiety scale (DAAS)
Time frame: post-intervention (8 weeks)
Depression and Anxiety scale (DAAS)
Time frame: follow-up (20 weeks)
Depression and Anxiety scale (DAAS)
Time frame: post-intervention (8 weeks)
Pain catastrophizing scale (PCS)
Time frame: follow-up (20 weeks)
Pain catastrophizing scale (PCS)
Time frame: post-intervention (8 weeks)
Chronic pain acceptance questionaire (CPAQ)
Time frame: follow-up (20 weeks)
Chronic pain acceptance questionaire (CPAQ)
Time frame: post-intervention (8 weeks)
Mindfulness Attention and Awerness scale (MAAS)
Time frame: follow-up (20 weeks)
Mindfulness Attention and Awerness scale (MAAS)
Time frame: post-intervention (8 weeks)
Body Awareness questionaire (BAQ)
Time frame: follow-up (20 weeks)
Body Awareness questionaire (BAQ)
Time frame: post-intervention (8 weeks)
Adverse events
Time frame: follow-up (20 weeks)
Adverse events
Universität Duisburg-Essen
Other
Yoga and Mindfulnes-based-stress-reduction for Patients With Tension-type Headache
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04857671
Brain Diseases, Central Nervous System Diseases
Namsos, Norway
View Trial DetailsNCT06604637
Brain Diseases, Central Nervous System Diseases
Bitlis, Turkey (Türkiye)
View Trial DetailsNCT06155669
Agnosia, Analgesia
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT05893004
Brain Diseases, Central Nervous System Diseases
Winterthur, Switzerland
View Trial Details